Neomycin And Polymyxin B Sulfates And Dexamethasone Ointment
Product Images NDC 80425-0229

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neomycin And Polymyxin B Sulfates And Dexamethasone (NDC 80425-0229). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanced Rx Pharmacy Of Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Desc 1 (Description 1)

Desc 1 (Description 1)
Chemical structure diagram of the active ingredient neomycin as part of the pharmaceutical product neomycin and polymyxin B sulfates with dexamethasone.*
FDA Label Image

Desc 2 (Description 2)

Desc 2 (Description 2)
Chemical structure diagram showing various polymyxin forms labeled B1, B2, B3, and B1-I with corresponding chemical groups R, R', X, and Y substitutions. Molecular formula C56H98N16O13 and molecular weight 1203.48 are also displayed.*
FDA Label Image

Desc 3 (Description 3)

Desc 3 (Description 3)
Chemical structure of dexamethasone, showing the molecular formula C22H29FO5 and molecular weight 392.46, illustrating its atomic composition and bonding arrangement.*
FDA Label Image

Desc (Description)

Desc (Description)
Chemical structure of Neomycin, as displayed in the image, including its molecular formula C23H46N6O13·xH2SO4 and molecular weight (M) 615 (base). The diagram shows the arrangement of atoms and bonds in the compound.*
FDA Label Image

Label 1 (Neo Polymyx B Dexa 80425 0229 01)

Label 1 (Neo Polymyx B Dexa 80425 0229 01)
Label for NEOMYCIN AND POLYMYXIN B SULFATES AND DEXAMETHASONE ophthalmic ointment, 3.5g, distributed by Advanced Rx Pharmacy of Tennessee, LLC. The label includes storage instructions (20°-25°C), a comparison to DEXASPORIN, NDC numbers 80425-0229-01 and source NDC 24208-0795-35, lot number 35DEX, and an expiration date of 6/30/2025. The manufacturer indicated is Bausch Health U S.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.